This inventor holds 6 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 2013-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsubuka, JP (2016)
- Tsukuba, JP (2013 - 2021)
Company Filing History:
Years Active: 2013-2024
Title: Innovations by Naoko Fujita in Transdermal Delivery Systems
Introduction
Naoko Fujita, a notable inventor located in Tsukuba, Japan, has made significant contributions to the field of transdermal drug delivery systems. With six patents to her name, her work primarily focuses on creating effective patches that enhance drug delivery while maintaining user comfort.
Latest Patents
Her latest innovations include a patch designed with dimethylsulfoxide (DMSO) in the adhesive layer. This patch features a backing layer with a water vapor transmission rate exceeding 400 g/m·24 hours, coupled with an adhesive layer that incorporates a drug, DMSO, and a specific adhesive formulation. The result is a durable patch that remains securely in place, even with prolonged wear. Another patent showcases a patch that combines a backing layer with an adhesive layer containing butorphanol and its pharmaceutically acceptable salts, along with a unique combination of rubber-based and silicone-based adhesive bases, ensuring optimal performance and adhesion.
Career Highlights
Naoko Fujita works with Hisamitsu Pharmaceutical Company, Inc., where her research and innovative designs have contributed to the advancement of transdermal patches. Her focus on improving drug delivery methods addresses some of the pressing challenges in the pharmaceutical industry.
Collaborations
Throughout her career, Fujita has collaborated with esteemed colleagues such as Takito Shima and Arata Toshimitsu. These partnerships have allowed for greater exploration of ideas and developments in transdermal technology, resulting in impactful advancements in the field.
Conclusion
Naoko Fujita stands out as a pioneering inventor in the realm of transdermal drug delivery systems. Her innovations, particularly the patches incorporating DMSO, exemplify her commitment to enhancing patient care through effective pharmaceutical solutions. As she continues to collaborate and innovate, her contributions will undoubtedly lead to further advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile